Suppr超能文献

引产过程中缩宫素应持续使用多长时间?

For how long should oxytocin be continued during induction of labour?

作者信息

Daniel-Spiegel Etty, Weiner Zeev, Ben-Shlomo Izhar, Shalev Eliezer

机构信息

Department of Obstetrics and Gynecology, Ha'Emek Medical Center, Afula, Israel.

出版信息

BJOG. 2004 Apr;111(4):331-4. doi: 10.1111/j.1471-0528.2004.00096.x.

Abstract

OBJECTIVE

To answer the question of whether oxytocin induction of labour should be discontinued when active labour begins.

DESIGN

We enrolled patients admitted for induction of labour with oxytocin. Exclusion criteria for induction of labour included non-vertex presentation, past history of more than one caesarean delivery, multiple pregnancies, persistent non-reassuring fetal heart rate before induction of labour and estimated fetal weight of more than 4250 g.

SETTING

Department of Obstetrics and Gynecology, Ha'Emek Medical Center, Afula, Israel.

POPULATION

Patients who were admitted for induction of labour in Ha'Emek Medical Center from 1st February 1998 to 29th February 2000.

METHODS

Patients were randomly divided into two groups. In group A, infusion of oxytocin was incremental until 5 cm dilation and maintained at the same level from that point throughout the labour. In group B, infusion of oxytocin was incremental but was discontinued when cervical dilatation reached 5 cm. Comparison between the two groups was made using Wilcoxon rank-sum test and Fisher's exact test.

MAIN OUTCOME MEASURE

Primary outcome variable was duration from induction to delivery. The secondary outcome variables included: duration of labour stages, maximal dosage and total amount of oxytocin used, the use of analgesia, abnormalities in fetal heart rate and episodes of uterine hyperstimulation. We also recorded mode of delivery, together with maternal and neonatal outcome.

RESULTS

One hundred and four patients participated in this study. The active phase of labour was shorter in group B compared with group A, but this difference was not statistically significant (2.6 +/- 2 vs 3.3 +/- 2.9, P= 0.07). In group A there were six caesarean deliveries and in group B only three. No significant differences were found when the other outcome parameters were compared.

CONCLUSIONS

There is no advantage in continuing oxytocin infusion after the onset of active labour.

摘要

目的

回答活跃期开始时是否应停止缩宫素引产的问题。

设计

我们纳入了因缩宫素引产而入院的患者。引产的排除标准包括非头先露、既往剖宫产史超过一次、多胎妊娠、引产开始前持续胎心异常以及估计胎儿体重超过4250克。

地点

以色列阿富拉市哈埃梅克医疗中心妇产科。

研究对象

1998年2月1日至2000年2月29日期间在哈埃梅克医疗中心因引产入院的患者。

方法

将患者随机分为两组。A组中,缩宫素输注量逐渐增加直至宫口扩张5厘米,并从该点起在整个产程中维持在同一水平。B组中,缩宫素输注量逐渐增加,但当宫颈扩张达到5厘米时停止。使用Wilcoxon秩和检验和Fisher精确检验对两组进行比较。

主要观察指标

主要结局变量是从引产到分娩的持续时间。次要结局变量包括:产程各阶段的持续时间、缩宫素的最大用量和总量、镇痛药物的使用、胎心异常以及子宫过度刺激的发作次数。我们还记录了分娩方式以及母婴结局。

结果

104名患者参与了本研究。与A组相比,B组的活跃期较短,但这种差异无统计学意义(2.6±2 vs 3.3±2.9,P = 0.07)。A组有6例剖宫产,B组只有3例。比较其他结局参数时未发现显著差异。

结论

活跃期开始后继续输注缩宫素没有优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验